Drug in Ozempic may enable patients with newly diagnosed type 1 diabetes to stave off insulin use, small study suggests

​ A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes stop taking insulin after three to six months in a small study. Read More Breaking News, Latest News and Videos | CNN